Skip to main content

Table 1 Common tumor markers levels in patients with obstructive jaundice before biliary drainage

From: Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas

Disease

No. (%)

CA19–9 (U/mL)

P value

CEA (ng/mL)

P value

CA125 (U/mL)

P value

Malignant lesions

102

474.4 (151.8–1325.5)

3.7 (2.5–7.1)

27.6 (12.1–62.0)

Pancreatic cancer

44 (43.1%)

494.5 (173.5–1743.3)

4.28 (3.0–9.2)

43.4 (22.6–163.9)

Periampullary cancer

31 (30.4%)

404.2 (79.5–872.0)

0.394a

4.5 (3.3–6.3)

0.926

30.2 (12.2–87.8)

0.559

Bile duct cancer

16 (15.7%)

571 (158.7–1321.0)

0.825a

3.2 (2.2–5.1)

0.081

11.8 (7.4–14.3)

0.001

Other types of cancers

11 (10.8%)

252 (112.1–595.7)

0.178a

2.6 (2.1–9.3)

0.271

50.0 (13.8–121.0)

0.949

Benign lesions

19

267.7 (141.9–639.9)

0.176b

2.55 (2.1–4.0)

0.074

10.0 (7.8–232.1)

0.486

  1. a Compared with pancreatic cancer.
  2. b Compare with malignant lesions